Cohance Lifesciences Ltd.

BSE: 543064 | NSE: COHANCE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE03QK01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Cohance Lifesc Cohance Lifesciences Ltd. | BSE 776.20 -10.15 (-1.29%) | NSE 778.95 -7.50 (-0.95%) | Trade | Add

BSE Live

Oct 30, 16:01

776.20 -10.15 (-1.29%)

Volume

AVERAGE VOLUME

5-Day

17,800

10-Day

17,817

30-Day

23,635

118,122

NSE Live

Oct 30, 15:59

778.95 -7.50 (-0.95%)

Volume

AVERAGE VOLUME

5-Day

249,599

10-Day

282,567

30-Day

675,950

1,750,195

Financials

Print/Copy to Excel : Go

Cash Flow of Cohance Lifesciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
Net Profit/Loss Before Extraordinary Items And Tax	351.35	408.77	579.39	722.45	413.98
Net CashFlow From Operating Activities	301.03	370.65	484.17	269.89	329.73
Net Cash Used In Investing Activities	-320.94	-381.58	-235.57	-90.36	-257.66
Net Cash Used From Financing Activities	20.81	-13.78	-235.79	-156.41	-76.55
Foreign Exchange Gains / Losses	0.00	0.00	0.00	0.00	0.00
Adjustments On Amalgamation Merger Demerger Others	0.00	0.00	0.00	0.00	0.00
Net Inc/Dec In Cash And Cash Equivalents	0.90	-24.71	12.81	23.12	-4.48
Cash And Cash Equivalents Begin of Year	18.46	43.02	30.21	7.09	11.58
Cash And Cash Equivalents End Of Year	19.36	18.31	43.02	30.21	7.09